Mechanisms of serotonergic affect control.
Dept. of Neurochemistry, Institute of Neurology, London, UK.
G A
GA
Kennett
D017371:8-Hydroxy-2-(di-n-propylamino)tetralin; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy / Q000503:physiopathology*; D001569:Benzodiazepines / Q000494:pharmacology; D002065:Buspirone / Q000494:pharmacology; D003220:Conflict, Psychological; D003863:Depression / Q000503:physiopathology; D015536:Down-Regulation / Q000187:drug effects; D005246:Feedback; D006801:Humans; D007398:Interpersonal Relations; D010879:Piperazines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D011903:Raphe Nuclei / Q000187:drug effects / Q000502:physiology; D051381:Rats; D011985:Receptors, Serotonin / Q000145:classification / Q000187:drug effects / Q000502:physiology; D012701:Serotonin / Q000502:physiology*; D012702:Serotonin Antagonists / Q000494:pharmacology; D013764:Tetrahydronaphthalenes / Q000494:pharmacology
D014151:Anti-Anxiety Agents; D010879:Piperazines; D011743:Pyrimidines; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; D013764:Tetrahydronaphthalenes; D001569:Benzodiazepines; C018406:1-(3-trifluoromethylphenyl)piperazine; D012701:Serotonin; D017371:8-Hydroxy-2-(di-n-propylamino)tetralin; C039979:gepirone; C015068:1-(3-chlorophenyl)piperazine; D002065:Buspirone